GreenCore Solutions Launches B2B Peptide Trading Hub Across 35 Countries
Event summary
- GreenCore Solutions Corp. launched A2A-Peptides.ai, a gated B2B hub for licensed peptide trading partners on September 22, 2026.
- The platform operates in nine jurisdictions covering 35 countries and is built on Microsoft Azure in the United States.
- At launch, the hub includes 5,301 product presentations and 24,694 provider records from licence registers.
- The service offers fixed-fee tools for licensed businesses, including AEO, listing, answer agent, and AI agent functionalities.
The big picture
GreenCore Solutions is expanding its AI agent infrastructure into the licensed peptide trade, building on its existing A2A-Cosmetics.ai platform. This move aligns with the growing trend of AI-driven B2B commerce and the increasing regulatory scrutiny in the healthcare and cosmetics sectors. The launch underscores the company's strategy to leverage AI agents for specialized markets, potentially positioning it as a key player in the intersection of biotechnology and digital commerce.
What we're watching
- Market Adoption
- How quickly licensed manufacturers, wholesalers, pharmacies, and prescribers will integrate the platform into their operations.
- Regulatory Compliance
- Whether the platform can maintain compliance with the nine different rule sets across 35 countries.
- Competitive Positioning
- The pace at which GreenCore Solutions can differentiate A2A-Peptides.ai from potential competitors in the licensed peptide trade space.
Related topics